Company profile

Spiden AG

Spiden aspires to become the benchmark platform for longevity and preventative medicine by providing real-time biomarker and drug analysis to empower clinicians, patients, as well as healthy individuals in making more informed and timely decisions and increase the safety and efficacy of medical treatments. It has developed the world's first data generation platform to perform spectroscopic measurements of a wide range of biomarkers and drugs in blood.

More news about Spiden AG

27.01.2022 16:00

ZKB Pionierpreises Technopark: Nominierte sind bekannt

Please login or
register to use the
awards follow feature
Spiden AG

Founded
2017

Kanton
Schwyz


LinkedIn

Homepage

rss